CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research Major trials in coronary intervention from 2018 The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document

Original Research2016 Jul 19;68(3):313-321.

JOURNAL:J Am Coll Cardiol. Article Link

Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines

Rodriguez F, Mahaffey KW. Keywords: acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment

FULL TEXT PDF